Back | Next |
home / stock / jnce / jnce message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: JNCE 23% v7,1M c10.95 f34,2M H 11.72 S10.53 | znewcar1 | investorshangout | 09/15/2020 8:35:59 PM |
17 Million float... Chart Looping Sweet Maybelinne 13 | europtiger | investorshub | 09/15/2020 5:56:20 PM |
Weeeeee..... passed $11!!!!! | now invest | investorshub | 09/15/2020 4:52:27 PM |
Weeeee | europtiger | investorshub | 09/15/2020 3:02:23 PM |
Passed it!! :-) | now invest | investorshub | 09/15/2020 2:56:13 PM |
Agile be 10 soon imo | europtiger | investorshub | 09/03/2020 2:44:32 PM |
znewcar1: JNCE 55% v43,0M c7.53 f34,0M preMH11.81 S@6.67 strong aft | znewcar1 | investorshangout | 09/01/2020 8:21:48 PM |
* * $JNCE Video Chart 09-01-2020 * * | ClayTrader | investorshub | 09/01/2020 8:21:26 PM |
And just above... lol | europtiger | investorshub | 09/01/2020 3:47:16 PM |
Volume | europtiger | investorshub | 09/01/2020 3:46:44 PM |
With the. Olive i just Bought some below | europtiger | investorshub | 09/01/2020 3:46:22 PM |
Great news today!! | now invest | investorshub | 09/01/2020 1:38:58 PM |
TYPICAL ALGO MM GAP & TRAP | TheFinalCD | investorshub | 09/01/2020 1:19:34 PM |
Nice JNCEmoving up!!! Currently up 8.99% today!! | now invest | investorshub | 08/25/2020 5:40:55 PM |
JNCE at ASCO 5-29/31 | microcapbiotech | investorshub | 05/23/2020 10:47:17 PM |
$JNCE buy 8.99 (8,99) | stocktrademan | investorshub | 12/13/2019 7:14:45 AM |
$10 on deck | Paul Wall | investorshub | 12/10/2019 10:30:11 PM |
Run done....falling knife is sharp | the rook | investorshub | 12/05/2019 3:26:59 PM |
* * $JNCE Video Chart 12-04-2019 * * | ClayTrader | investorshub | 12/04/2019 11:17:24 PM |
Gonna take a starter tomorrow.. | jan_ds | investorshub | 12/03/2019 10:47:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Jounce Therapeutics Inc. Company Name:
JNCE Stock Symbol:
NASDAQ Market:
Jounce Therapeutics Inc. Website:
CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Co...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. ("Jounce" or t...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE)...